Hospitals are still on quite fragile financial footing if you look beneath the surface, according to new Kaufman Hall data. Rising costs, uneven patient volumes, and ongoing reimbursement and payer mix pressures continue to limit the sector’s financial recovery. The post Hospital Margins Squeeze as Costs Outpace Revenue Growth appeared first on MedCity News.
ST. LOUIS — Violent crime was already trending down from a covid-era spike when President Donald Trump presented a picture of unbridled crime in America on the campaign trail in 2024. Now his administration has eliminated about $500 million in grants to organizations that buttress public safety, including many working to prevent gun violence. In…
It looks like the answer is ‘yes’. KFF reports that Holden Karau, a software engineer from the San Francisco Bay Area, created an AI tool to help appeal insurance denials. She calls it: Fight Health Insurance, How does it work? You’ve gotta make a scan of the denial letter from your insurance company, and run…
The 15 drugs selected for the Centers for Medicare and Medicaid Services drug price negotiation program accounted for about $27 billion in total prescription spending under Medicare Parts B and D. But this revenue from Medicare makes up a small percentage of each drug manufacturer’s total sales. The post With CMS’s New List of Meds…
Prior authorization is a sore subject for payers and providers. So what if it went away? In a recent fireside chat hosted by MedCity News, Don Antonucci, CEO of Providence Health Plan, shared his thoughts. The post Video: What Would Happen If Prior Authorization Went Away? appeared first on MedCity News.
The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights. The partners will abstract data from thousands of medical charts of patients enrolled in the American Cancer Society’s research studies, with the ultimate goal of shortening research timelines. The post…
Rocket Pharmaceuticals voluntarily withdrew its FDA submission for its Fanconi anemia gene therapy. The move follows a corporate restructuring over the summer that refocused the company on its cardiovascular programs. The post Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy appeared first on MedCity News.
On January 11, 2026, the Appropriations Committee released the FY 2026 National Security, Department of State and Related Programs (NSRP) (formerly State, Foreign Operations, and Related Programs [SFOPs]) appropriations bill and accompanying explanatory statement. The bill and explanatory statement include funding for U.S. global health programs at the State Department.
“It’s going to be the biggest infusion of federal dollars into rural health care in American history.” Robert F. Kennedy Jr. on Sept. 4, 2025, in a Senate hearing At a September Senate hearing, Health and Human Services Secretary Robert F. Kennedy Jr. boasted about a rural health initiative within President Donald Trump’s “One Big…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…